ANI Pharmaceuticals | ANIP - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
AbbVie USD 3.59B 28.65B 2025-12
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Canopy Growth CAD 34.82M 14.85M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Emergent BioSolutions USD 112.2M 500K 2023-12
Heron Therapeutics USD 8.97M 24K 2026-03
Hikma Pharmaceutical USD 715M 104M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.32B 134M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Perrigo USD 434.8M 39.7M 2026-03
Sun Pharmaceuticals INR 73.34B 6.28B 2026-03
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06